Skip to main content
. 2020 Jul 17;10:11876. doi: 10.1038/s41598-020-68516-y

Figure 5.

Figure 5

CSCs after compound 1 treatment. Notes Percentage of CD44+CD24 CSCs after treatment with compound 1 for 48 h in MDA-MB 231 (A) and in the MDA-MB-453 cell line (B) and CD133+ CSCs in the MDA-MB-453 cell line (C). Data represent are expressed as a mean from experiment performed in triplicate ± SD. Columns, mean of cells; bars, SD; *P < 0.05, ***P < 0.001. CSCs cancer stem cells, SD standard deviation.